Catalyst overview
Research summary
This catalyst tracks a Phase 2 data readout for IPN10200 in Moderate to Severe Upper Facial Lines (Glabellar lines). The expected timing is based on the latest available company guidance and may change.
07/30/26:- May Ph2 glabellar data positive; further upper facial lines data expected H2 2026.
Verification
Confirm timing and program details against the company announcement or filing.